Cargando…

Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment

Major depressive disorder (MDD) is associated with a significantly elevated risk of developing serious medical illnesses such as cardiovascular disease, immune impairments, infection, dementia and premature death. Previous work has demonstrated immune dysregulation in subjects with MDD. Using genome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mellon, S H, Wolkowitz, O M, Schonemann, M D, Epel, E S, Rosser, R, Burke, H B, Mahan, L, Reus, V I, Stamatiou, D, Liew, C -C, Cole, S W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070063/ https://www.ncbi.nlm.nih.gov/pubmed/27219347 http://dx.doi.org/10.1038/tp.2016.79

Ejemplares similares

Leukocyte Telomere Length in Major Depression: Correlations with Chronicity, Inflammation and Oxidative Stress - Preliminary Findings
por: Wolkowitz, Owen M., et al.
Publicado: (2011)

Shorter telomere length predicts poor antidepressant response and poorer cardiometabolic indices in major depression
por: Rampersaud, Ryan, et al.
Publicado: (2023)

Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder
por: Lindqvist, Daniel, et al.
Publicado: (2018)

Blood-based mitochondrial respiratory chain function in major depression
por: Fernström, Johan, et al.
Publicado: (2021)

Dimensions of childhood adversity differentially affect biological aging in major depression
por: Rampersaud, Ryan, et al.
Publicado: (2022)

Of sound mind and body: depression, disease, and accelerated aging
por: M. Wolkowitz, Owen, et al.
Publicado: (2011)

“GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder
por: Protsenko, Ekaterina, et al.
Publicado: (2021)

Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder
por: Goetzl, Edward J., et al.
Publicado: (2021)

Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response
por: Hervé, Mylène, et al.
Publicado: (2017)

Peripheral telomere length and hippocampal volume in adolescents with major depressive disorder
por: Henje Blom, E, et al.
Publicado: (2015)

Neuroscience-informed auditory training in schizophrenia: A final report of the effects on cognition and serum brain-derived neurotrophic factor()
por: Fisher, Melissa, et al.
Publicado: (2015)

Brain grey matter volume alterations associated with antidepressant response in major depressive disorder
por: Liu, Jia, et al.
Publicado: (2017)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Epigenetic alterations in depression and antidepressant treatment
por: Menke, Andreas, et al.
Publicado: (2014)

The effect of antidepressant treatment on white matter integrity in Major Depression
por: Tourjman, S., et al.
Publicado: (2022)

An electroencephalographic signature predicts antidepressant response in major depression
por: Wu, Wei, et al.
Publicado: (2020)

Changes in leukocytes and CRP in different stages of major depression
por: Singh, Deepti, et al.
Publicado: (2022)

The ABCB1 transporter gene and antidepressant response
por: Peters, Eric J, et al.
Publicado: (2009)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

PHENOTYPIC EXPRESSIONS OF THE MAJOR HISTOCOMPATIBILITY LOCUS IN MAN (HL-A): LEUKOCYTE ANTIGENS AND MIXED LEUKOCYTE CULTURE REACTIVITY
por: Amos, D. Bernard, et al.
Publicado: (1968)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale
por: Liu, Tzu-Yu, et al.
Publicado: (2020)

Association of plasma cytokines and antidepressant response following mild-intensity whole-body hyperthermia in major depressive disorder
por: Flux, Michael C., et al.
Publicado: (2023)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

Blue Again: Perturbational Effects of Antidepressants Suggest Monoaminergic Homeostasis in Major Depression
por: Andrews, Paul W., et al.
Publicado: (2011)

Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2018)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
por: Dam, V. H., et al.
Publicado: (2021)

Research Letter: Application of GPT-4 to select next-step antidepressant treatment in major depression
por: Perlis, Roy H.
Publicado: (2023)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
por: Lee, K.H., et al.
Publicado: (2022)

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
por: Sanacora, Gerard, et al.
Publicado: (2017)

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
por: Haupt, T.H., et al.
Publicado: (2023)

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022)

The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy
por: Carta, Mauro Giovanni, et al.
Publicado: (2010)

Antidepressant Treatment Normalizes White Matter Volume in Patients with Major Depression
por: Zeng, Ling-Li, et al.
Publicado: (2012)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Brain arousal regulation as response predictor for antidepressant therapy in major depression
por: Schmidt, Frank M., et al.
Publicado: (2017)

Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
por: Pehrson, Alan L, et al.
Publicado: (2015)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
por: An, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ug718tq4rk87nl05tki8eq0nj